TFDA Manufacturing Approval Received: Innocreate SARS-CoV-2 QD Kit
Innocreate SARS-CoV-2 QD Kit Receives TFDA Manufacturing Approval TFDA Manufacturing Approval serves as the definitive seal of quality and safety for medical devices in Taiwan, and Innocreate Bioscience is proud to announce that our advanced diagnostic solution has officially reached this milestone. On July 24, 2020, the Taiwan Food and Drug Administration (TFDA) granted manufacturing approval to the Innocreate SARS-CoV-2 QD Kit. This significant achievement marks a pivotal turning point […]
TFDA Manufacturing Approval Received: Innocreate SARS-CoV-2 QD Kit Read More